Company intelligence / Profile preview

Valendo Health

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Valendo Health launched in 2023 to help independent endocrinology practices move to value-based care by providing technology, telehealth tools, remote patient monitoring, a data-driven platform, and operational expertise. Initial roll-out is commercial, not drug-based, with results focused on increasing endocrinologist capacity and improving patient outcomes in diabetes management.

Therapeutic areas: EndocrinologyMetabolic Disorders
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Cecelia HealthAdvanced Metabolic Care & Research (AMCR)

Beyond the preview

Go deeper on Valendo Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Valendo Health.

Explore the full profile